Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Discovering How Disease Develops
Probes in mouse cells.
Tiny chemical sensors implanted into patients could help diagnose disease and track its progress.

Researchers have developed tiny probes comprising gold-coated particles. These can be inserted into cells, enabling diseases to be detected and monitored remotely using light from a laser.

Once the probe is inside a cell, laser light shone on to it is absorbed then re-emitted, causing nearby proteins in the cell to vibrate according to their shape.

Because molecules change shape as disease progresses, they give rise to different vibrational frequencies. Scientists can measure and interpret these vibrations, to understand how the cell is responding to disease.

Gold is used to coat the sensor because it is an unreactive metal, preventing the body from rejecting the implant. The laser technique is highly sensitive, fast and uses a low-power laser.

Scientists say the probes could be a useful tool to learn more about diseases at a very small scale, by observing how molecules interact. Further studies will look at diseases linked to the immune system in the first instance, but researchers say the technique has potential to help doctors diagnose and monitor a range of conditions.

Dr Colin Campbell, who led the research, said: "By creating a sensor that can safely be implanted into tissue and combining this with a sensitive light-measurement technique, we have developed a useful device that will help diagnose and track disease in patients."

The research, funded by EaStCHEM, the Scottish Universities Physics Alliance and the Engineering and Physical Sciences Research Council, was published in the journals Chemical Communications, the Journal of Biophotonics and ACSNano.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.